BAP1 Mutant Malignant Pleural Mesothelioma (MPM): Outcomes with Chemotherapy, ICPi and PARPi

被引：1
|
作者：
Dudnik, E. [1 ]
Bar, J. [2 ]
Kuznetsov, T. [2 ]
Moskovitz, M. [3 ]
Dudnik, J. [4 ]
Shochat, T. [5 ]
Zer, A. [1 ]
Urban, D. [2 ]
机构：
[1] Rabin Med Ctr, Davidoff Canc Ctr, Thorac Canc Serv, Petah Tiqwa, Israel
[2] Chaim Sheba Med Ctr, Inst Oncol, Ramat Gan, Israel
[3] Rambam Hlth Care Campus, Thorac Canc Serv, Haifa, Israel
[4] Soroka Univ Med Ctr, Inst Canc, Beer Sheva, Israel
[5] Rabin Med Ctr, Stat Consulting Unit, Petah Tiqwa, Israel
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
BAP1; immune check-point inhibitors; poly (ADP-ribose) polymerase inhibitors;
D O I：
10.1016/j.jtho.2019.08.1632
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.06-14
引用
收藏
页码：S760 / S760
页数：1
相关论文
共 50 条
  • [1] Clinical characteristics of patients with malignant pleural mesothelioma (MPM) harboring somatic BAP1 mutations
    Zauderer, Marjorie Glass
    Bott, Matthew Joseph
    McMillan, Robert
    Sima, Camelia S.
    Rusch, Valerie W.
    Krug, Lee M.
    Ladanyi, Marc
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [2] BAP1 in advanced sporadic malignant pleural mesothelioma
    El Bastawisy, A.
    Shehab, R.
    Bahnassy, A.
    Sabri, N.
    ANNALS OF ONCOLOGY, 2017, 28
  • [3] BAP1 gene mutations in Egyptian patients with advanced sporadic malignant pleural mesothelioma (MPM): relation with clinical outcomes and survival
    Bahnasy, Abeer A.
    El-Din, Raghda Shehab
    Sabri, Nagwa Ali
    Abdel-Rahman, Chand. A.
    El Bastawisy, Ahmed
    CANCER GENETICS, 2018, 228 : 83 - 92
  • [4] BAP1 Protein is a Progression Factor in Malignant Pleural Mesothelioma
    Arzt, Lisa
    Quehenberger, Franz
    Halbwedl, Iris
    Mairinger, Thomas
    Popper, Helmut H.
    PATHOLOGY & ONCOLOGY RESEARCH, 2014, 20 (01) : 145 - 151
  • [5] BAP1 expression and treatment outcomes in malignant mesothelioma
    Kumar, Neelam
    Kolluri, Krishna
    Sage, Elizabeth
    Borg, Elaine
    Falzon, Mary
    Nicholson, Andrew
    Janes, Sam
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [6] BAP1 and miR-31 combination predicts outcomes in epithelioid malignant pleural mesothelioma
    Murrone, Albero
    Cantini, Luca
    Pecci, Federica
    Cognigni, Valeria
    Copparoni, Cecilia
    Rinaldi, Silvia
    Fiordoliva, Ilaria
    Monaco, Federica
    Rubini, Corrado
    Barbisan, Francesca
    Cimadamore, Alessia
    Giampieri, Riccardo
    Bianchi, Francesca
    Tomasetti, Marco
    Amati, Monica
    Santarelli, Lory
    Berardi, Rossana
    JOURNAL OF THORACIC DISEASE, 2021, 13 (10) : 5741 - 5751
  • [7] BAP1 facilitates diagnostic objectivity, classification, and prognostication in malignant pleural mesothelioma
    McGregor, Stephanie M.
    Dunning, Ryan
    Hyjek, Elizabeth
    Vigneswaran, Wickii
    Husain, Aliya N.
    Krausz, Thomas
    HUMAN PATHOLOGY, 2015, 46 (11) : 1670 - 1678
  • [8] Meningiomas in Patients With Malignant Pleural Mesothelioma Harboring Germline BAP1 Mutations
    Hu, Zishuo, I
    Miettinen, Markku
    Quezado, Martha
    Lebensohn, Alexandra P.
    Aldape, Kenneth
    Agra, Maria
    Wagner, Cathy
    Mallory, Yvonne
    Hassan, Raffit
    Ghafoor, Azam
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (03) : 461 - 466
  • [9] BAP1 EXPRESSION AND TREATMENT OUTCOMES IN MALIGNANT PLEURAL MESOTHELIOMA IN A PROSPECTIVE UK BASED CLINICAL TRIAL
    Kumar, N.
    Kolluri, K.
    Al Rifai, D.
    Ishii, Y.
    Borg, E.
    Falzon, M.
    Nicholson, A.
    Janes, S.
    THORAX, 2017, 72 : A16 - A17
  • [10] Diagnostic utility of BAP1 for malignant pleural mesothelioma in pleural fluid specimens with atypical morphology
    Louw, Amber
    Lee, Y. C. Gary
    Acott, Nathan
    Creaney, Jenette
    Vliet, Chris
    Chai, Siaw Ming
    CYTOPATHOLOGY, 2022, 33 (01) : 84 - 92
12345